Dr. Robert David Kaplan, MD

Dr. Kaplan practices at Delray Medical Center in Delray Beach, Florida, part of Tenet Healthcare.

Dr. Kaplan's NPI, 1407810476, was assigned on April 14, 2006. Dr. Kaplan graduated from Weill Cornell Medicine in 1979. Dr. Kaplan holds Florida license ME132562.

Dr. Kaplan's primary practice is Delray Medical Center, at 5352 Linton Blvd, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 498-4440.

Dr. Kaplan's primary practice is Delray Medical Center in Delray Beach, Florida, part of Tenet Healthcare. Dr. Kaplan is also affiliated with Kingman Regional Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Kaplan to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kaplan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kaplan's licenses on file in 6 states: Florida, Maine, Arizona, North Carolina, Pennsylvania and Michigan.

Dmand AI lists gastrointestinal bleeding, intestinal or bowel obstruction and pancreas or bile duct endoscopy (ERCP) among the conditions Dr. Kaplan treats.

CMS data shows 1,562 Medicare services from Dr. Kaplan across 18 procedure codes in 2024, for 736 Medicare patients. Medicare paid $149,656 for them.

CMS counts 736 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 75 to 84, with 296 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 72, with 51% women.

In 2024, Dr. Kaplan wrote 92 Medicare Part D claims for 75 patients. 70% of them were for generic drugs. CMS names the drug for 52 of them, across 4 drugs with 11 or more claims each, at $2,448 in total drug cost. In 2019, CMS named 289 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kaplan for performance year 2024, reported as part of a group. Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 203 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kaplan, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Kaplan in 2020. Dr. Kaplan's most frequent co-authors are Scott J. Cotler, MD, Marc D. Gellman, MD and Gregory A. Talavera, MD.

Dmand AI links Dr. Kaplan to 5 clinical trials, 4 of them phase 3 studies. Conditions studied include Constipation, Abdominal Pain and Gastroparesis. Bausch Health Americas, Inc. sponsors the most, 3.

CMS Open Payments shows 88 general payments to Dr. Kaplan from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Allergan Inc. paid the most, $10,911.

Dmand AI lists 2 awards for Dr. Kaplan, most recently CMS Stage 1 EHR in 2013.

Dr. Kaplan graduated from Weill Cornell Medicine in 1979. Dr. Kaplan is a member of ACG.

Dr. Kaplan is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.